Cargando…
More effective drugs lead to harder selective sweeps in the evolution of drug resistance in HIV-1
In the early days of HIV treatment, drug resistance occurred rapidly and predictably in all patients, but under modern treatments, resistance arises slowly, if at all. The probability of resistance should be controlled by the rate of generation of resistance mutations. If many adaptive mutations ari...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
eLife Sciences Publications, Ltd
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4764592/ https://www.ncbi.nlm.nih.gov/pubmed/26882502 http://dx.doi.org/10.7554/eLife.10670 |
_version_ | 1782417398910943232 |
---|---|
author | Feder, Alison F Rhee, Soo-Yon Holmes, Susan P Shafer, Robert W Petrov, Dmitri A Pennings, Pleuni S |
author_facet | Feder, Alison F Rhee, Soo-Yon Holmes, Susan P Shafer, Robert W Petrov, Dmitri A Pennings, Pleuni S |
author_sort | Feder, Alison F |
collection | PubMed |
description | In the early days of HIV treatment, drug resistance occurred rapidly and predictably in all patients, but under modern treatments, resistance arises slowly, if at all. The probability of resistance should be controlled by the rate of generation of resistance mutations. If many adaptive mutations arise simultaneously, then adaptation proceeds by soft selective sweeps in which multiple adaptive mutations spread concomitantly, but if adaptive mutations occur rarely in the population, then a single adaptive mutation should spread alone in a hard selective sweep. Here, we use 6717 HIV-1 consensus sequences from patients treated with first-line therapies between 1989 and 2013 to confirm that the transition from fast to slow evolution of drug resistance was indeed accompanied with the expected transition from soft to hard selective sweeps. This suggests more generally that evolution proceeds via hard sweeps if resistance is unlikely and via soft sweeps if it is likely. DOI: http://dx.doi.org/10.7554/eLife.10670.001 |
format | Online Article Text |
id | pubmed-4764592 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2016 |
publisher | eLife Sciences Publications, Ltd |
record_format | MEDLINE/PubMed |
spelling | pubmed-47645922016-02-25 More effective drugs lead to harder selective sweeps in the evolution of drug resistance in HIV-1 Feder, Alison F Rhee, Soo-Yon Holmes, Susan P Shafer, Robert W Petrov, Dmitri A Pennings, Pleuni S eLife Genomics and Evolutionary Biology In the early days of HIV treatment, drug resistance occurred rapidly and predictably in all patients, but under modern treatments, resistance arises slowly, if at all. The probability of resistance should be controlled by the rate of generation of resistance mutations. If many adaptive mutations arise simultaneously, then adaptation proceeds by soft selective sweeps in which multiple adaptive mutations spread concomitantly, but if adaptive mutations occur rarely in the population, then a single adaptive mutation should spread alone in a hard selective sweep. Here, we use 6717 HIV-1 consensus sequences from patients treated with first-line therapies between 1989 and 2013 to confirm that the transition from fast to slow evolution of drug resistance was indeed accompanied with the expected transition from soft to hard selective sweeps. This suggests more generally that evolution proceeds via hard sweeps if resistance is unlikely and via soft sweeps if it is likely. DOI: http://dx.doi.org/10.7554/eLife.10670.001 eLife Sciences Publications, Ltd 2016-02-14 /pmc/articles/PMC4764592/ /pubmed/26882502 http://dx.doi.org/10.7554/eLife.10670 Text en © 2016, Feder et al http://creativecommons.org/licenses/by/4.0/ This article is distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use and redistribution provided that the original author and source are credited. |
spellingShingle | Genomics and Evolutionary Biology Feder, Alison F Rhee, Soo-Yon Holmes, Susan P Shafer, Robert W Petrov, Dmitri A Pennings, Pleuni S More effective drugs lead to harder selective sweeps in the evolution of drug resistance in HIV-1 |
title | More effective drugs lead to harder selective sweeps in the evolution of drug resistance in HIV-1 |
title_full | More effective drugs lead to harder selective sweeps in the evolution of drug resistance in HIV-1 |
title_fullStr | More effective drugs lead to harder selective sweeps in the evolution of drug resistance in HIV-1 |
title_full_unstemmed | More effective drugs lead to harder selective sweeps in the evolution of drug resistance in HIV-1 |
title_short | More effective drugs lead to harder selective sweeps in the evolution of drug resistance in HIV-1 |
title_sort | more effective drugs lead to harder selective sweeps in the evolution of drug resistance in hiv-1 |
topic | Genomics and Evolutionary Biology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4764592/ https://www.ncbi.nlm.nih.gov/pubmed/26882502 http://dx.doi.org/10.7554/eLife.10670 |
work_keys_str_mv | AT federalisonf moreeffectivedrugsleadtoharderselectivesweepsintheevolutionofdrugresistanceinhiv1 AT rheesooyon moreeffectivedrugsleadtoharderselectivesweepsintheevolutionofdrugresistanceinhiv1 AT holmessusanp moreeffectivedrugsleadtoharderselectivesweepsintheevolutionofdrugresistanceinhiv1 AT shaferrobertw moreeffectivedrugsleadtoharderselectivesweepsintheevolutionofdrugresistanceinhiv1 AT petrovdmitria moreeffectivedrugsleadtoharderselectivesweepsintheevolutionofdrugresistanceinhiv1 AT penningspleunis moreeffectivedrugsleadtoharderselectivesweepsintheevolutionofdrugresistanceinhiv1 |